Company / SG&A Expense
OPKO HEALTH, INC. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$223.0M
FY2025
5-year range
$223.0M / $468.9M
FY2021-FY2025
Trend
-26.7%
vs FY2024
Sector context
#66 of 213
Health Care
What the data says
At $223M, OPKO HEALTH, INC.'s sg&a expense ranks #148 of 213 in the Health Care sector. SG&A Expense has fluctuated over the past 10 years, ranging from $223M in FY2025 to $469M in FY2021.
Based on SEC 10-K filings.
$223M in FY2025 with a 5-year CAGR of -9.1%.
Improved from $301M to $223M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -15.7%
- 5-Year CAGR
- -9.1%
- 10-Year CAGR
- -
Sector benchmark
#148 of 213 in Health CareTop 69% of 213This company $223.0M Sector average $722.3M
▼
-69.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -9.1%, indicating a declining trend.
- In FY2025, sg&a expense decreased 26.7% year-over-year.
- Ranks #66 out of 213 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.08 (distress zone, below 1.8 threshold)
- Negative profit margin: -7.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $223.0M | -26.7% |
| FY2024 | $304.2M | +1.2% |
| FY2023 | $300.6M | -19.4% |
| FY2022 | $372.7M | -20.5% |
| FY2021 | $468.9M | +30.8% |
| FY2020 | $358.3M | +4.4% |
| FY2019 | $343.3M | -15.7% |
| FY2018 | $407.3M | -1.8% |
| FY2017 | $414.6M | +1.8% |
| FY2016 | $407.3M | +107.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026